Skip to content

Clinical trials

Completed Attention Deficit Disorder with Hyperactivity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Status: Completed Clear all

1,147 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20019
20028
200323
200441
200557
200644
200749
200863
200950
201051
201142
201252
201349
201464
201556
201658
201750
201858
201950
202032
202146
202251
202350
202442
202516
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,147

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company50
Massachusetts General Hospital45
Shire44
Children's Hospital Medical Center, Cincinnati28
National Taiwan University Hospital26
Otsuka Pharmaceutical Development & Commercialization, Inc.19
Karolinska Institutet15
Supernus Pharmaceuticals, Inc.15
Florida International University14
New York State Psychiatric Institute14

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity1,147
Autism Spectrum Disorder48
Oppositional Defiant Disorder33
Spasm33
Anxiety Disorders28
Conduct Disorder27
Substance-Related Disorders22
Autistic Disorder20
Neurodevelopmental Disorders20
Attention Deficit and Disruptive Behavior Disorders18

Trials

Showing 51 to 75 of 1,147. Each trial links to its page on Pharma Observatory.

1,047 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.